<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vmireaviz</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-762X</issn><issn pub-type="epub">2782-1579</issn><publisher><publisher-name>РЕАВИЗ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20340/vmi-rvz.2023.5.CLIN.6</article-id><article-id custom-type="elpub" pub-id-type="custom">vmireaviz-746</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая медицина</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical medicine</subject></subj-group></article-categories><title-group><article-title>Методы ранней диагностики и фармакологической профилактики панкреатита после эндоскопической папиллосфинктеротомии.</article-title><trans-title-group xml:lang="en"><trans-title>Methods of early diagnosis and pharmacological prevention of pancreatitis after endoscopic papillosphincterotomy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-4154-4672</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Спиридонов</surname><given-names>Т. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Spiridonov</surname><given-names>T. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Спиридонов Тимур Романович - студент,</p><p> </p></bio><bio xml:lang="en"><p>Timur R. Spiridonov - student,</p><p>281 Kommunarov st., Izhevsk, 426056</p></bio><email xlink:type="simple">jmlrmpx16ajs@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-8942-7081</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новикова Екатерина Денисовна - студентка,</p><p>ORCID 0009-0008-8942-7081; Kot1999.12.03@yandex.ru</p></bio><bio xml:lang="en"><p>Ekaterina D. Novikova - student,</p><p>281 Kommunarov st., Izhevsk, 426056</p></bio><email xlink:type="simple">Kot1999.12.03@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-2622-0615</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ельцов</surname><given-names>Т. О.</given-names></name><name name-style="western" xml:lang="en"><surname>El'cov</surname><given-names>T. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ельцов Тимофей Олегович - студент,</p><p>ул. Коммунаров, д. 281, Ижевск, 426056</p></bio><bio xml:lang="en"><p>Timofey O. Eltsov - student,</p><p>281 Kommunarov st., Izhevsk, 426056</p></bio><email xlink:type="simple">wernest@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ижевская государственная медицинская академия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Izhevsk State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2023</year></pub-date><volume>13</volume><issue>5</issue><fpage>77</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Спиридонов Т.Р., Новикова Е.Д., Ельцов Т.О., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Спиридонов Т.Р., Новикова Е.Д., Ельцов Т.О.</copyright-holder><copyright-holder xml:lang="en">Spiridonov T.R., Novikova E.D., El'cov T.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestnik.reaviz.ru/jour/article/view/746">https://vestnik.reaviz.ru/jour/article/view/746</self-uri><abstract><sec><title>Введение</title><p>Введение. Самое частое осложнение эндоскопической папиллосфинктеротомии (ЭПСТ) – острый панкреатит. Предполагают, что в основе этого осложнения лежит механическое, химическое, гидростатическое, ферментное и тепловое воздействия на протоки и паренхиму поджелудочной железы. По разным литературным данным, частота пост-ЭПСТ панкреатита (ПЭП) варьирует от 30 до 40 %, а летальность составляет 2–10 %.</p><p>Целью исследования служило расширение информации об особенностях ранней диагностики и профилактики пост-ЭПСТ панкреатита на современном этапе.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Для достижения поставленной цели проанализированы 559 историй болезни пациентов с диагностированной желчнокаменной болезнью, 319 из которых проходили ЭПСТ.</p></sec><sec><title>Результаты</title><p>Результаты. В ходе исследования выявлено, что достоверными методами ранней диагностики считаем повышенный уровень отношения нейтрофилов к лимфоцитам – более 4,96 (p = 0,001), высокий уровень лактатдегидрогеназы (ЛДГ) – более 250 МЕ/мл (p = 0,01), а также соотношение С-реактивного белка к альбуминам более 0,180 (p = 0,001). При этом косвенными диагностическими маркерами ПЭП являются биохимические признаки холестаза и цитолиза гепатоцитов, а также гипергликемия в сочетании с глюкозурией. Наиболее эффективной стратегией профилактики ПЭП считаем включение интраоперационных инъекций краёв папиллотомной раны эпинефрином в сочетании с последующим приемом соматостатина в комплексе с ректальным диклофенаком и внутривенной гидратацией реамберином.</p></sec><sec><title>Выводы</title><p>Выводы. Таким образом, можно сделать вывод, что несмотря на проводимые исследования и поиски эффективных алгоритмов профилактики и ранней диагностики ПЭП, их данные зачастую противоречат друг другу или просто не подтверждают свою эффективность. Проблема профилактики и диагностики ПЭП остаётся сложной и требует дальнейшего изучения. В современной литературе имеются расхождения, иногда существенные, что даёт основания для разработки и исследования новых методов ранней диагностики и профилактики.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The most frequent complication of endoscopic papillosphincterotomy (EPST) is acute pancreatitis. This complication is supposed to be based on mechanical, chemical, hydrostatic, enzymatic and thermal impact on pancreatic ducts and parenchyma. According to different literature data, the incidence of post-EPST pancreatitis (PEP) varies from 30 to 40 %, and the mortality rate is 2–10 %.</p><p>The aim of the investigation was to expand information about peculiarities of early diagnostics and prevention of post-EST pancreatitis at the present stage.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. To reach the set goal we analyzed 559 case histories of patients with diagnosed cholelithiasis, 319 of them underwent EPST.</p></sec><sec><title>Results</title><p>Results. During the study it was found out, that elevated neutrophils/lymphocytes ratio over 4,96 (p = 0,001), high LDH level over 250 IU/ml (p = 0,01), as well as Creactive to albumin index over 0,180 (p = 0,001) are reliable markers of early diagnosis. Also, indirect diagnostic markers of PEEP are biochemical signs of cholestasis and cytolysis of hepatocytes, as well as hyperglycemia combined with glucosuria. We consider the inclusion of intraoperative injections of papillotomy wound margins with Epinephrine in combination with subsequent Somatostatin administration in combination with rectal Diclofenac and intravenous hydration with Reamberin to be the most effective strategy for PEP prevention.</p></sec><sec><title>Conclusions</title><p>Conclusions. Thus, we can conclude that despite the ongoing research and the search for effective algorithms for the prevention and early diagnosis of PEP, their data often contradict each other or simply do not confirm their effectiveness. The problem of prevention and diagnosis of PEP remains complex and requires further study. There are discrepancies, sometimes significant ones, in the current literature, which provides grounds for the development and research of new methods of early diagnosis and prevention.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эндоскопическая папиллосфинктеротомия</kwd><kwd>панкреатит</kwd><kwd>профилактика</kwd><kwd>диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pancreatitis</kwd><kwd>papillosphincterotomy</kwd><kwd>prevention</kwd><kwd>diagnosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ogura T., Imoto A., Okuda A. et al. Can Iodixanol Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Prospective, Randomized, Controlled Trial. Dig Dis. 2019; 37:255.</mixed-citation><mixed-citation xml:lang="en">1 Ogura T., Imoto A., Okuda A. et al. Can Iodixanol Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Prospective, Randomized, Controlled Trial. Dig Dis. 2019; 37:255.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dumonceau J.M., Kapral C., Aabakken L. et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020;52:127.</mixed-citation><mixed-citation xml:lang="en">2 Dumonceau J.M., Kapral C., Aabakken L. et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020;52:127.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Morales S.J., Sampath K., Gardner T.B. A Review of Prevention of Post-ERCP Pancreatitis. Gastroenterol Hepatol (N Y) 2018;14:286.</mixed-citation><mixed-citation xml:lang="en">3 Morales S.J., Sampath K., Gardner T.B. A Review of Prevention of Post-ERCP Pancreatitis. Gastroenterol Hepatol (N Y) 2018;14:286.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J., Wan J.H., Wu D.Y. et al. Assessing Quality of Precut Sphincterotomy in Patients With Difficult Biliary Access: An Updated Metaanalysis of Randomized Controlled Trials. J Clin Gastroenterol . 2018;52:573.</mixed-citation><mixed-citation xml:lang="en">4 Chen J., Wan J.H., Wu D.Y. et al. Assessing Quality of Precut Sphincterotomy in Patients With Difficult Biliary Access: An Updated Metaanalysis of Randomized Controlled Trials. J Clin Gastroenterol . 2018;52:573.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Park C.H., Park S.W., Yang M.J. et al. Pre-and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis. Surg Endosc. 2022;36:2052.</mixed-citation><mixed-citation xml:lang="en">5 Park C.H., Park S.W., Yang M.J. et al. Pre-and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis. Surg Endosc. 2022;36:2052.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Devière J. Post-ERCP pancreatitis: still a major issue despite all efforts. Endoscopy. 2021;53:367.</mixed-citation><mixed-citation xml:lang="en">6 Devière J. Post-ERCP pancreatitis: still a major issue despite all efforts. Endoscopy. 2021;53:367.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Buxbaum J.L., Freeman M., Amateau S.K. et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc. 2023;97:153.</mixed-citation><mixed-citation xml:lang="en">7 Buxbaum J.L., Freeman M., Amateau S.K. et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc. 2023;97:153.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Padberg S., Tissen-Diabaté T., Dathe K. et al. Safety of diclofenac use during early pregnancy: A prospective observational cohort study. Reprod Toxicol. 2018;77:122.</mixed-citation><mixed-citation xml:lang="en">8 Padberg S., Tissen-Diabaté T., Dathe K. et al. Safety of diclofenac use during early pregnancy: A prospective observational cohort study. Reprod Toxicol. 2018;77:122.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu L., Li C., Huang Y., Jin H. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis. J Gastrointest Surg. 2019;23:1991.</mixed-citation><mixed-citation xml:lang="en">9 Liu L., Li C., Huang Y., Jin H. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis. J Gastrointest Surg. 2019;23:1991.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Serrano JPR, de Moura DTH, Bernardo WM et al. Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Endosc Int Open. 2019; 7:E477.</mixed-citation><mixed-citation xml:lang="en">10 Serrano JPR, de Moura DTH, Bernardo WM et al. Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Endosc Int Open. 2019; 7:E477.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tomoda T., Kato H., Ueki T. et al. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography. Gastroenterology. 2019;156:1753.</mixed-citation><mixed-citation xml:lang="en">11 Tomoda T., Kato H., Ueki T. et al. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography. Gastroenterology. 2019;156:1753.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Boškoski I., Costamagna G. How to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Gastroenterology. 2020;158:2037.</mixed-citation><mixed-citation xml:lang="en">12 Boškoski I., Costamagna G. How to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Gastroenterology. 2020;158:2037.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tse F., Liu J., Yuan Y. et al. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database Syst Rev. 2022;3:CD009662.</mixed-citation><mixed-citation xml:lang="en">13 Tse F., Liu J., Yuan Y. et al. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database Syst Rev. 2022;3:CD009662.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Li D.F., Yang M.F., Chang X. et al. Endocut Versus Conventional Blended Electrosurgical Current for Endoscopic Biliary Sphincterotomy: A Meta-Analysis of Complications. Dig Dis Sci. 2019; 64:2088.</mixed-citation><mixed-citation xml:lang="en">14 Li D.F., Yang M.F., Chang X. et al. Endocut Versus Conventional Blended Electrosurgical Current for Endoscopic Biliary Sphincterotomy: A Meta-Analysis of Complications. Dig Dis Sci. 2019; 64:2088.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
